Reason for request
The actual benefit of these medicinal products is substantial.
Clinical Added Value
|no clinical added value||
CARDENSIEL does not provide any improvement in actual benefit (IAB V) in the management of chronic stable heart failure with reduced systolic left ventricular function in addition to angiotensin-converting enzyme (ACE) inhibitors, and diuretics, and optionally cardiac glycosides.